01 — Immunotherapy
Nanoparticle immunotherapies
Development of nanoparticle-based immunotherapies for infectious diseases including tuberculosis and malaria.
Research
Work is ongoing in four areas.
Host-directed therapy, pulmonary delivery, immune-cell biology, and formulation science. The programmes are the spine of the Infectious Disease Nanomedicine Research Group.
02 — Pulmonary delivery
Inhalable particles
Development of inhalable particles for treatment of tuberculosis.
03 — Host biology
Nanoparticles and immune cells
Studies of the interaction of nanoparticles and immune cells in the context of infectious diseases.
04 — Formulation
Infectious-disease drug delivery
Synthesis and evaluation of nanoparticles for infectious-disease drug delivery.